Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66764-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- CKB antibody
- Antibody type
- Monoclonal
- Description
- CKB antibody (Cat. #66764-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2B7C3
- Vial size
- 20ul, 150ul
Submitted references Peroxisomal metabolism of branched fatty acids regulates energy homeostasis.
Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype.
RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression.
Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice.
Liu X, He A, Lu D, Hu D, Tan M, Abere A, Goodarzi P, Ahmad B, Kleiboeker B, Finck BN, Zayed M, Funai K, Brestoff JR, Javaheri A, Weisensee P, Mittendorfer B, Hsu FF, Van Veldhoven PP, Razani B, Semenkovich CF, Lodhi IJ
Nature 2025 Oct;646(8087):1223-1231
Nature 2025 Oct;646(8087):1223-1231
Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype.
Gao ZJ, Fang H, Sun S, Liu SQ, Fang Z, Liu Z, Li B, Wang P, Sun SR, Meng XY, Wu Q, Chen CS
Theranostics 2024;14(8):3104-3126
Theranostics 2024;14(8):3104-3126
RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression.
Ren J, Huang B, Li W, Wang Y, Pan X, Ma Q, Liu Y, Wang X, Liang C, Zhang Y, Wang S, Yang F, Li H, Ning H, Jiang Y, Qin C, Ran A, Xiao B
Translational oncology 2024 Apr;42:101904
Translational oncology 2024 Apr;42:101904
Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice.
Zhu J, Jin Z, Yang L, Zhao C, Hu J, Chen J, Han Y, Yu P, Luo J, Kong L, Zhang C
Pharmacological research 2022 Jun;180:106240
Pharmacological research 2022 Jun;180:106240
No comments: Submit comment
No validations: Submit validation data